Search results for "beta-alanine"

showing 3 items of 23 documents

Risk Assessment of "Other Substances"-Beta-Alanine

2018

chemistry.chemical_compoundFood supplementchemistrybusiness.industryAdverse health effectMedicinebeta-AlaninePharmacologybusinessRisk assessmentEuropean Journal of Nutrition & Food Safety
researchProduct

Effect of sodium bicarbonate and beta-alanine supplementation on maximal sprint swimming

2013

Background. This study examined the effect of simultaneous supplementation of extracellular buffer sodium bicarbonate (SB) and intracellular buffer beta-alanine (BA) on maximal sprint swimming. Methods. Thirteen competitive male swimmers completed 4 different treatments (placebo [PL], SB, BA + PL, and BA + SB) in a crossover procedure. PL or SB supplementation (0.3 g/kg body weight) was ingested 60 min before two maximal 100-m freestyle swims that were performed with a passive recovery of 12-min between each swim. Because of the known long washout period for carnosine, four weeks of BA supplementation (4.8 g per day) was started after the first week of PL or SB supplementation and performan…

medicine.medical_specialtyAlkalosisPassive recoverybeta-AlanineCarnosineErgogenic aidergogenic aidchemistry.chemical_compoundAnimal sciencemedicineBlood lactatealkaloosiSodium bicarbonateNutrition and Dieteticsbusiness.industryanaerobinen kuormitusergogeeninen apukeinoAlkalosismedicine.diseaseanaerobic exercisechemistrySprintAnaerobic exercisePhysical therapyalkalosisbufferbusinessAnaerobic exercisehuman activitiesBufferpuskuriResearch ArticleFood ScienceJournal of the International Society of Sports Nutrition
researchProduct

Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants

2010

An increasing number of patients receive anticoagulant therapy to prevent and treat arterial or venous thromboembolism. The major complication of anticoagulant therapy is the increase of the individual bleeding risk. All anticoagulant drugs can cause haemorrhages, that can sometimes be life-threatening. Although heparins and the vitamin K antagonists have been the most widely used anticoagulants for decades, the correct management of bleeding complications associated with these agents has been poorly studied. More recently, new anticoagulant drugs, both parenteral and oral, have been approved for clinical use. Currently, none of these new agents has a specific antidote, and little advise ca…

medicine.medical_specialtyVitamin Kmedicine.drug_classMorpholinesHemorrhageFactor VIIaThiophenesVitamin kFondaparinuxDabigatranRivaroxabanPolysaccharidesRisk FactorsDrug DiscoverymedicineHumansProtaminesIntensive care medicinePharmacologyRivaroxabanHeparinbusiness.industryAntithrombinAnticoagulantAnticoagulantsHeparinRecombinant ProteinsDabigatranFondaparinuxbeta-AlanineBenzimidazolesComplicationbusinessBleeding anticoagulantsmedicine.drugCurrent Pharmaceutical Design
researchProduct